Elevated MMP-12 protein levels in induced sputum from patients with COPD

Background: Several matrix metalloproteinases (MMPs) are involved in the pathogenesis of chronic obstructive pulmonary disease (COPD). In mice, MMP-12 plays a crucial role in the development of cigarette smoke induced emphysema. A study was undertaken to investigate the role of MMP-12 in the development of COPD in human smokers. Methods: Induced sputum samples were collected from patients with stable COPD (n = 28), healthy smokers (n = 14), never smokers (n = 20), and former smokers (n = 14). MMP-12 protein levels in induced sputum were determined by ELISA and compared between the four study groups. MMP-12 enzymatic activity in induced sputum was evaluated by casein zymography and by cleaving of a fluorescence quenched substrate. Results: Median (IQR) MMP-12 levels were significantly higher in COPD patients than in healthy smokers, never smokers, and former smokers (17.5 (7.1–42.1) v 6.7 (3.9–10.4) v 4.2 (2.4–11.3) v 6.1 (4.5–7.6) ng/ml, p = 0.0002). MMP-12 enzymatic activity was significantly higher in patients with COPD than in controls (4.11 (1.4–8.0) v 0.14 (0.1–0.2) μg/μl, p = 0.0002). Conclusion: MMP-12 is markedly increased in induced sputum from patients with stable COPD compared with controls, suggesting a role for MMP-12 in the development of COPD in smokers.

[1]  L. Hirsch Competing interests: none declared. , 2006 .

[2]  M. Eppihimer,et al.  Cigarette smoke condensate induces MMP-12 gene expression in airway-like epithelia. , 2005, Biochemical and biophysical research communications.

[3]  J. Gunn,et al.  Human bronchial epithelial cells express and secrete MMP-12. , 2004, Biochemical and biophysical research communications.

[4]  D. Corry,et al.  An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema , 2004, PLoS medicine.

[5]  William C. Parks,et al.  Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.

[6]  R. Sansores,et al.  Matrix metalloproteinases activity in COPD associated with wood smoke. , 2004, Chest.

[7]  V. Lagente,et al.  Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease , 2004, Inflammation Research.

[8]  R. Pauwels,et al.  Chronic obstructive pulmonary disease: molecular and cellularmechanisms , 2003, European Respiratory Journal.

[9]  A. Churg,et al.  Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha release. , 2003, American journal of respiratory and critical care medicine.

[10]  N. Kaminski,et al.  Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysema , 2003, Nature.

[11]  C. Bolliger,et al.  Progress in Respiratory Research , 2003 .

[12]  N. Kaminski,et al.  Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. , 2003, Nature.

[13]  P. Sterk,et al.  Safety of sputum induction , 2002, European Respiratory Journal.

[14]  R. Djukanović,et al.  Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation , 2002, European Respiratory Journal.

[15]  P. Barnes,et al.  Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory cell and molecular biology.

[16]  N. Anthonisen,et al.  The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. , 2002, Human molecular genetics.

[17]  David E. Misek,et al.  Profiling Changes in Gene Expression during Differentiation and Maturation of Monocyte-derived Dendritic Cells Using Both Oligonucleotide Microarrays and Proteomics* , 2001, The Journal of Biological Chemistry.

[18]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[19]  S. Shapiro,et al.  Macrophage Metalloelastase Inhibitors , 2001 .

[20]  P. Barnes,et al.  New drugs for asthma, allergy and COPD , 2001 .

[21]  R. Homer,et al.  Interferon γ Induction of Pulmonary Emphysema in the Adult Murine Lung , 2000, The Journal of experimental medicine.

[22]  B. Ma,et al.  Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. , 2000, The Journal of clinical investigation.

[23]  J. Banchereau,et al.  The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface , 1999, European journal of immunology.

[24]  S. Weiss,et al.  Characterization of matrix metalloproteinases produced by rat alveolar macrophages. , 1999, American journal of respiratory cell and molecular biology.

[25]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[26]  H. V. Van Wart,et al.  Hydrolysis of a Broad Spectrum of Extracellular Matrix Proteins by Human Macrophage Elastase* , 1997, The Journal of Biological Chemistry.

[27]  R. Senior,et al.  Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of alpha 1-antitrypsin. , 1994, Biochemical and biophysical research communications.

[28]  T. Ley,et al.  Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. , 1993, The Journal of biological chemistry.

[29]  S. Weiss,et al.  Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity. , 1991, The Journal of clinical investigation.

[30]  Z. Werb,et al.  Limited proteolysis by macrophage elastase inactivates human alpha 1- proteinase inhibitor , 1980, The Journal of experimental medicine.